Quick Answer
VOLITIONRX LTD reported Cash and Equivalents of $20.73 million for fiscal year 2023.
VOLITIONRX LTD Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2023 | $20.73M | +90.8% |
| 2022 | $10.87M | -47.2% |
| 2021 | $20.58M | +5.8% |
| 2020 | $19.44M | +14.6% |
| 2019 | $16.97M | +26.4% |
| 2018 | $13.43M | +32.7% |
| 2017 | $10.12M | -53.3% |
| 2016 | $21.68M | +266.4% |
| 2015 | $5.92M | +176.6% |
| 2014 | $2.14M | +468.2% |
| 2012 | $376.4K | +8.2% |
| 2011 | $347.9K | +632.7% |
| 2010 | $47.5K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| March 31, 2024 | $11.77M | +17.6% | -43.2% |
| December 31, 2023 | $20.73M | +90.8% | +91.8% |
| September 30, 2023 | $10.81M | -34.2% | -45.3% |
| June 30, 2023 | $19.74M | +18.0% | +97.2% |
| March 31, 2023 | $10.01M | -57.8% | -7.9% |
| December 31, 2022 | $10.87M | -47.2% | -33.8% |
| September 30, 2022 | $16.42M | -28.3% | -1.9% |
| June 30, 2022 | $16.73M | -40.1% | -29.5% |
- VOLITIONRX LTD showed an increase of +90.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2023 period, VOLITIONRX LTD’s cash and equivalents has grown by 43559.5% (from $47.5 thousand to $20.73 million).
- The most recent figure is from VOLITIONRX LTD’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 25, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: